Biotechnology | Disease | FDA | Therapeutics
The FDA approved new treatment for adults with Cushing’s disease
On Mar. 6, 2020, the FDA approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either…
Government of Canada invested $27 million in Coronavirus research
On Mar. 6, 2020, the Government of Canada announced an investment of nearly $27 million to fund Coronavirus…
German lab demonstrated feasibility to detect SARS-Coronavirus-2 using Hologic’s Panther Fusion System
On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on…
Heat Biologics collaborated with University of Miami to develop COVID-19 Coronavirus vaccine
On Mar. 5, 2020, Heat Biologics announced a strategic collaboration with the University of Miami Miller School of…
Biotechnology | CDC | COVID-19 | Diagnostics
Quest Diagnostics planned launch for coronavirus disease 2019 (COVID-19) test
On Mar. 5, 2020, Quest Diagnostics announced it will launch a coronavirus (COVID-19) test service. The new test…
Cocrystal Pharma announced plans to advance Coronavirus program
On Mar. 6, 2020, Cocrystal Pharma announced it had initiated its Coronavirus program. Cocrystal previously entered into a…
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
Vir Biotec and Alnylam expanded collaboration to advance RNAi therapeutics for reatment of Coronavirus Infection
On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…
Biotechnology | CRISPR | Disease | Genomics | Therapeutics
Oregon Health Sciences doctors first to use CRISPR editing for inherited form of blindness
On Mar. 4, 2020, doctors at the Casey Eye Institute at Oregon Health & Science University in Portland…
Luminex provided updates on critical efforts related to novel Coronavirus
On Mar. 4, 2020, Luminex announced they were working on multiple solutions to augment their NxTAG and ARIES…
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
BioReference Laboratories and State of New Jersey provided testing for Coronavirus 2019
On Mar. 20, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the State of New…
Biotechnology | COVID-19 | Diagnostics | Life Science History | Non-Profit Research | Therapeutics | Vaccine
Boston University NEIDL scientists joined international Coronavirus research effort
On Mar. 2, 2020, Boston’s top infectious disease researchers, including scientists from Boston University’s National Emerging Infectious Diseases…
Gilead acquired Forty Seven for $49 billion in cash
On Mar. 2, 2020, Gilead Sciences announced it had acquired Forty Seven for $95.50 per share in cash…
Biotechnology | COVID-19 | FDA | Therapeutics
Mateon updated Rapid Antiviral Response Program Initially targeting COVID-19
On Mar. 2, 2020, Mateon Therapeutics reported the company had been evaluating its therapeutic and AI platforms to…
Innovation Pharma provided scientific rationale and clinical development perspectives for Brilacidin as potential Coronavirus treatment
On Mar. 2, 2020, Innovation Pharma provided the scientific rationale and clinical development perspectives for Brilacidin, the Company’s…
University of Washington Medicine received FDA permission to conduct coronavirus tests
On Feb. 29, 2020, the University of Washington (UW) Medicine Clinical Virology Lab announced it had received U.S….
Mutations can reveal how the coronavirus moves, but they’re easy to overinterpret
On Feb. 28, 2020, immediately after Christian Drosten published a genetic sequence of the novel coronavirus online, he…
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
On Feb. 27, 2020, a consortium of philanthropic, non-profit and private sector organisations launched a collaboration that aims…
Innovation Pharma shipped Brilacidin to U.S. Regional Biocontainment Laboratory for research against Coronavirus COVID-19
On Feb. 27, 2020, Innovation Pharma announced the Company had signed a Material Transfer Agreement (MTA) with one…
NIH announced $1 million prize competition to target global disease diagnostics
On Feb. 25, 2020, the U. S. National Institutes of Health (NIH) announced it had launched a $1…
Georgia Tech and Shriners Hospitals for Children announced new collaborative research affiliation
On Feb. 26, 2020, Georgia Institute of Technology and Shriners Hospitals for Children announced a collaborative research affiliation…
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
Tonix Pharma announced collaboration with Southern Research to develop vaccine to protect against COVID-19 based on Horsepox virus
On Feb. 26, 2020, Tonix Pharmaceuticals announced a strategic collaboration with Southern Research to support the development of…
NIH clinical trial of remdesivir to treat COVID-19 began for adults with coronavirus disease
On Feb. 25, 2020, the National Institutes of Health (NIH) announced that a randomized, controlled clinical trial to…
Cherokee Nation became first U.S. tribe to preserve culturally important seeds in the Svalbard Global Seed Vault
On Feb. 25, 2020, the Cherokee Nation became the first U.S. tribe to preserve culturally important seeds in…
Pilot clinical trial in China to test University of British Columbia researcher’s findings as a targeted therapy for COVID-19
On Feb. 25, 2020, a University of British Columbia researcher was part of an international team working with…
Vir Biotec and WuXi Biologics announced collaboration for global development of antibodies to treat COVID-19
On Feb. 25, 2020, Vir Biotech announced a development and manufacturing collaboration to advance and produce human monoclonal…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
New technique helped uncover how Coronaviruses enter cells
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…
Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…